Indegene Inc - CA Los Angeles, Los Angeles 90010

Indegene Inc entered the industry of Medical Research in 2004 and has grown to employ 1 to 4 people, generating an annual revenue of $5.000.000 to $9.999.999. The NAICS classifies this business under the code 5611101, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.

To acquire more information, please contact Kiran John, Other by calling (323) 900-4900 during business hours. You can also write to the business’ Branch at 4727 Wilshire Boulevard # 403, Los Angeles, California CA 90010. You can also visit the company’s website at indegene.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Indegene Inc
Representative: Kiran John, Other
Place of Business: 4727 Wilshire Boulevard # 403, Los Angeles, CA 90010
Contact Number: (323) 900-4900
Website: indegene.com
Type of Service: Medical Research
SIC Number: 8733
NAICS Number: 5611101
Locality: Branch
Market Type: B2B (Business to Business)
Began: 2004
Income/Year: $5.000.000 to $9.999.999
Laborers: 1 to 4
Share This Company:

Indegene Inc is a company operating from Los Angeles, California providing professional Medical Research and relevant B2B variables. It was founded in 2004 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 5611101 as Medical Research.

With a current employee count of 1 to 4, Indegene Inc has gone to report making $5.000.000 to $9.999.999 per annum on its journey towards growth. This company invites you to contact its representative Kiran John, Other at (323) 900-4900 for related queries, or to locate its Branch using the coordinates 34.06205,-118.33241.

The Branch can also be found at the street address 4727 Wilshire Boulevard # 403 in Los Angeles, California 90010 and can be engaged online through the company website at indegene.com, the company Twitter , and Facebook page .